# Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC

> **NCT01063478** · PHASE1 · TERMINATED · sponsor: **University of Chicago** · enrollment: 3 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** RAD001 (in addition to standard radiation and chemotherapy)

## Key facts

- **NCT ID:** NCT01063478
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-06
- **Final completion:** 2012-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2014-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063478, "Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01063478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*